Recent News
PathPresenter introduces ConsultConnect, a zero footprint web portal for remote second opinions
PathPresenter, a leader in digital pathology workflow software, is pleased to announce ConsultConnect, a new solution for digital pathology consultations
Groundbreaking study unveils key mechanism for neuronal identity regulation
A team of researchers from the Institute for Neurosciences, a joint center of the Spanish National Research Council (CSIC) and
Liver cancer drug combo gets second FDA rejection over manufacturing issues
The FDA has once again rejected HLB and Jiangsu Hengrui Pharmaceuticals’ drug combination to treat the most common form of
Supercharge Your Portfolio with Future Health Stocks!
Join us for Profitable Insights & Expert Tips!
Latest Pharma News
Liver cancer drug combo gets second FDA rejection over manufacturing issues
The FDA has once again rejected HLB and Jiangsu Hengrui Pharmaceuticals’ drug combination to treat the most common form of
Alnylam hopes its broad ATTR-CM label can give Amvuttra an edge in heart disease
Alnylam will likely face challenges in turning a profit this year, despite executives promising to do so. But the label
Latest Cannabis News
Canadian Cannabis Sales Sank in January
Statistics Canada released January retail sales for the country, with cannabis sales decreasing from the December levels, down 14.9% to C$418.3 million.
Another Warning to Cannabis Investors
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015.
Latest biotech News
J&J boosts planned US manufacturing investment to $55B
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:
TOT BIOPHARM (1875.HK) Turns a Profit for the First Time, Reports 2024 Net Income of RMB 34.8M – Biotech Investments
EQS Newswire / 21/03/2025 / 22:00 UTC+8 Guru Club, March 12丨TOT BIOPHARM – B (1875.HK) announced that for the full-year
Latest Life Science News
PathPresenter introduces ConsultConnect, a zero footprint web portal for remote second opinions
PathPresenter, a leader in digital pathology workflow software, is pleased to announce ConsultConnect, a new solution for digital pathology consultations
Groundbreaking study unveils key mechanism for neuronal identity regulation
A team of researchers from the Institute for Neurosciences, a joint center of the Spanish National Research Council (CSIC) and
Latest psychedelics News
Dr. Albert Garcia-Romeu | Johns Hopkins University School of Medicine | Psychedelic Finance
Albert Garcia-Romeu, Ph.D. is an Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine.
Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – March 17, 2025) – Neural Therapeutics Inc. (CSE: NURL) (“Neural” or the “Company”), an ethnobotanical drug discovery company
videos
Popular Posts
